An apparatus for applying negative pressure to a tissue site of a patient may include a tissue interface, a cover, an aperture in the cover, and a sealing member. The tissue interface may have an anatomical shape configured to cover the tissue site. The cover may be configured to cover the tissue interface. The aperture in the cover may be fluidly coupled to the tissue interface. The sealing member may be configured to seal the cover to the patient, wherein the cover and the sealing member are configured to cooperate to form a sealed chamber containing the tissue interface. The tissue interface may be coupled to a source of negative pressure, which can be delivered to the tissue interface for distribution to the tissue site. The source of negative pressure may be coupled to the cover of the apparatus.

Disclosed dressing embodiments may include a tissue interface and a cover, with the tissue interface shaped anatomically for interaction with a specific anatomical region, such as a foot. Such tissue interface embodiments would typically comprise a manifold and a fluid control layer having a plurality of fluid restrictions, with the manifold disposed in a stacked relationship with the fluid control layer. Some embodiments of the tissue interface might also include a gel layer in a stacked relationship with the fluid control layer, opposite the manifold. For foot dressings, tissue interface embodiments may be shaped with a hindfoot section, an underfoot section, and a forefoot extension section.

A leg care apparatus includes a main body configured to provide an action space in which a leg is accommodated, a bottom module which is placed on a bottom surface of the main body and in which a component for a foot bath is accommodated, and an action space adjustment module configured to adjust a size of the action space.

A negative pressure wound treatment system comprising a bandage portion and a negative pressure portion. The bandage portion includes a dressing portion in contact with a wound and a sealing layer positioned in contact with the dressing portion. The sealing layer includes an adhesive creating a seal around the wound. The negative pressure portion is in fluid communication with the bandage portion and includes a first valve and a second valve. The first valve is in fluid communication with the bandage portion and the negative pressure portion. The second valve is in fluid communication with the negative pressure portion and the surrounding environment. The negative pressure wound treatment system is configured to provide negative pressure to an area sealed by the bandage portion upon the actuation of the negative pressure portion. The negative pressure portion is configured to be actuated by compressing the negative pressure portion while walking.

In a method for diagnosing and treating a patient having lesions in both arteries of left and right lower limbs. By determining that a lesion distal to an aortailiac bifurcation is to be treated first, catheters and an operation time can be reduced. The lesion to be treated first can be on a priority basis based on diagnostic data, deciding that a lesion proximal to the bifurcation is to be treated next, and then treating the lesions substantially continuously.

An apparatus for applying negative pressure to a tissue site of a patient may include a tissue interface, a cover, an aperture in the cover, and a sealing member. The tissue interface may have an anatomical shape configured to cover the tissue site. The cover may be configured to cover the tissue interface. The aperture in the cover may be fluidly coupled to the tissue interface. The sealing member may be configured to seal the cover to the patient, wherein the cover and the sealing member are configured to cooperate to form a sealed chamber containing the tissue interface. The tissue interface may be coupled to a source of negative pressure, which can be delivered to the tissue interface for distribution to the tissue site. The source of negative pressure may be coupled to the cover of the apparatus.

Noninvasive treatment (e.g., neuromodulation) can be achieved using vibrational energy applied via one or more wearable devices. A noninvasive treatment device includes a vibrational actuator disposed within a housing that can be secured to a user's body at or adjacent a treatment site. One or more sensors can collect physiological data before, during, or after application of vibrational energy to monitor a user's condition. Machine learning or other suitable approaches can be used to analyze sensor data to detect medical conditions and/or to effect treatment of medical conditions using devices as described herein.

The present invention relates to a skin protection device primarily comprised of a body with a top surface and a bottom surface, and a backing sheet. The body is preferably flexible and is manufactured from a biodegradable, waterproof, and UV-resistant/UV-blocking material that is plastic, fabric, or latex-based. In addition, the body may be infused with a plurality of zinc particles/compounds to protect against sun/UV damage and may have differing levels of SPF protection. The body is preferably colored to resemble the skin shade or tone of the user and has an adhesive bottom surface that can adhere to a user's skin. The body may be appropriately shaped in any conventional or non-conventional shape that may or may not mimic the shape of the body part it is being applied to.

The disclosed invention provides a skin therapy system for skin conditioning or treatment of a body part. The skin therapy system includes a body part shaped encaser including a first and second film substrate and an encaser liner disposed between the first and second film substrates. An outer peripheral edge of the encaser liner is sealed between outer peripheral edges of the first and second film substrates to create a hermetic seal forming a first fillable space between the first film substrate and a first layer of the encaser liner, a second fillable space between the second film substrate and a second layer of the encaser liner, and an internal volume defined by the first and second layers of the encaser liner and disposed between the first and second fillable spaces. The skin therapy system further includes a therapeutic composition contained within the first and second fillable spaces.

A negative pressure therapy dressing includes a drape layer, an adhesive border configured to provide a seal between the drape layer and skin, and a manifold layer coupled to the drape layer. The manifold layer includes a body portion extending in a first direction, a first wing positioned at a first side of the body portion, and a second wing positioned at a second side of the body portion opposite the first side. The first wing extends away from the first side and partially in the first direction such that a first gap is provided between a first tip of the first wing and the first side of the body portion. The second wing extends away from the second side and partially in the first direction such that a second gap is provided between a second tip of the second wing and the second side of the body portion.